Sitler C G, Turnage C S, McFadden B E, Smith E O, Adams J M
Department of Pulmonary Care, Woman's Hospital of Texas, Houston 77054.
J Perinatol. 1993 May-Jun;13(3):197-200.
Adverse reactions of infants to surfactant administration include loss of chest wall movement and decrease in oxygen saturation and heart rate. We are aware of no previous studies addressing the administration of surfactant. We studied 22 infants with respiratory distress syndrome to determine whether these adverse reactions could be reduced by giving surfactant slowly by microinfusion syringe pump. Loss of chest wall movement was significantly greater in infants receiving surfactant by the hand-dosing method as compared with administration of surfactant by pump. A significant increase in ventilator pressure interventions was observed when surfactant was given by standard hand bolus method compared with pump infusion. Heart rate and oxygen saturation did not differ significantly between the two techniques. These findings suggest that pump administration of surfactant minimized potential airway obstruction; thus it may be an alternative to standard bolus dosing techniques.
婴儿使用表面活性剂的不良反应包括胸壁运动丧失、氧饱和度和心率下降。我们知晓此前尚无关于表面活性剂给药的研究。我们对22例呼吸窘迫综合征婴儿进行了研究,以确定通过微量输注注射器泵缓慢给予表面活性剂是否可减少这些不良反应。与通过泵给予表面活性剂相比,采用手工给药法给予表面活性剂的婴儿胸壁运动丧失明显更严重。与泵输注相比,采用标准手工推注法给予表面活性剂时,观察到呼吸机压力干预显著增加。两种技术在心率和氧饱和度方面无显著差异。这些发现表明,通过泵给予表面活性剂可将潜在气道阻塞降至最低;因此,它可能是标准推注给药技术的一种替代方法。